BF Biosciences (BFBIO): Result Review: BFBIO 2QFY25 Diluted EPS Rs0.9 - By Sherman Research
- BF Biosciences (BFBIO):
- BF Biosciences (BFBIO) announced 2QFY25 result today where in company posted earnings of Rs80mn (diluted EPS of Rs0.9) as compared to net earnings of Rs52(EPS of 0.6) during the same period last year, up by 53%YoY. The result came in below our expectation due to lower revenue , higher selling & distribution expense, and higher finance cost.
- During 2QFY25, the company’s topline surged by 59% YoY to Rs1.33bn, primarily driven by increase in volume due to newly launched products.
- The company’s gross margin expanded to 47%, up 10ppt YoY from 37%...
